Success Metrics

Active Trials

4(67%)

Phase Distribution

Ph early_phase_1

17%

Ph phase_1

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

Phase 1Safety & dosage

5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Detailed Status

Recruiting3

Not yet recruiting2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)

Phase 15 (83.3%)

Trials by Status

active_not_recruiting117%

not_yet_recruiting233%

recruiting350%

Recent Activity

4 active trials

Showing 5 of 6

active_not_recruitingphase_1

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

NCT06946199

recruitingphase_1

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

NCT07215650

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07236411Phase 1

Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants

Active Not Recruiting

NCT07408869Phase 1

A Phase 1 Study of Cizutamig in IgE Mediated Diseases

Not Yet Recruiting

NCT07353450Early Phase 1

A Study of Cizutamig for Patients With Ulcerative Colitis

Not Yet Recruiting

NCT06946199Phase 1

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

Recruiting

NCT07215650Phase 1

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Recruiting

NCT07215663Phase 1

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Recruiting

All 6 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 6